top of page
1/4
Preventing chemotherapy-induced gut toxicities and inflammation
OUR MISSION
To improve lower gastrointestinal health by preventing chemotherapy-induced toxicities and inflammation caused due to dietary, xenobiotics and genetic factors.
September 2021
-
Sanarentero Awarded Phase I STTR award $400,000 for National Cancer Institute to Develop Drug Detoxifying Bacteria to Prevent Chemotherapy-induced Diarrhea
Our current technologies for gut protection are Drug detoxifying bacteria and Proprietary Botanical Product.
​
Interested investors can connect with us for further collaboration with our company.
bottom of page